Table 2. Level of expression of the different receptors targeted by sunitinib and sorafenib.
CSFR | FLT3 | KIT | PDGFR | RET | VEGFR1 | VEGFR2 | VEGFR3 | Score/8 | E Score | |
786-O | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 800 | |
+ | + | − | + | + | − | − | + | 5 | ||
ccRCC | 2 | 68 | 1284 | 139 | 100 | 112 | 5198 | 147 | 7050 | |
+ | + | + | + | + | − | + | + | 7 | ||
Met | 6 | 145 | 11039 | 332 | 50 | 3274 | 1297 | 128 | 16271 | |
+ | + | + | + | + | + | + | + | 8 |
(−) indicates that no or very low levels of detectable amplified cDNA were observed on an agarose gel; (+) indicates amplified cDNA. The Score/8 indicates the presence of receptorsargeted by sunitinib or sorafenib. The E Score indicates the relative expression level as detected by quantitative and semi-quantitative PCR. A level of sensitivity to sunitinib similar to that of 786-O cells is indicated by a grey background; sensitivity only to higher concentrations of the drug is indicated by a black background.